Description

Updated: This adoption modifies the information collected in the table of Note 3.A and adds Note 3.D for Property and Note 3.E for Life/Fraternal and Health companies to coincide with changes to SSAP No. 68 – Business Combinations and Goodwill and SSAP No. 97 – Investments in Subsidiary, Controlled and Affiliated Entities driven by the SAPWG adoption of AP&P Ref #2020-03 on 7/30/2020.

Effective Annual 2021

References: 2020-22BWG Modified; SSAP No. 68; SSAP No. 97; AP&P Ref #2020-03

Updated: The instructions have been updated to reflect editorial changes adopted by the NAIC Blanks Working Group (BWG) on 12/16/2020. This revision adds a reference to Note 5.Q, indicating the amounts disclosed as prepayment penalties and/or acceleration fees for securities sold, redeemed or otherwise disposed can be the result of a callable or tender offer feature.

Effective Annual 2021

References: NAIC Editorial Revisions to the Blanks and Instructions

New: The instructions and illustration have been updated to reflect changes associated with 2020-27BWG Modified (adopted 8/27/2020). Note 5.R will be data captured and should disclose the reporting entity’s share of the cash pool by asset type (cash, cash equivalents, or short-term investments). This disclosure was added to reflect requirements for qualified cash pools for SSAP No. 2R related to the SAPWG adoption of AP&P Ref #2019-42.

Note 5.R should only be reported (i.e., “Active” in Gain’s software), and the data-captured table completed, if a company reports investments in Qualified Cash Pools on Schedule E, Part 2, Line 8799999.

Effective 1st Quarter 2021

References: 2020-27BWG Modified; SSAP No. 2R; AP&P Ref #2019-42

New: The instructions and illustration have been updated to reflect changes associated with 2020-26BWG Modified (adopted 8/27/2020). The update to the instructions coincides with the disclosure changes to SSAP No. 86 – Derivatives, adopted by the SAPWG on July 30, 2020 (Ref #2019-38). Specifically, the updated instructions for Note 8.A(8) indicate the aggregate fair value of derivative instruments with financing premiums should be disclosed, excluding the impact of the deferred or financing premiums.

Effective 1st Quarter 2021

References: 2020-26BWG Modified; SSAP No. 86; AP&P Ref #2019-38

Updated: The instructions and illustrations have been updated to reflect editorial changes adopted by the NAIC Blanks Working Group (BWG) on 3/16/2021 and 5/26/2021. Specifically, this revision modifies the description in the data captured table of Note 10.O, Column 6 to “Amount of the Recognized Guarantee Under SSAP No. 5R” from the previous label of “Reported Value” to provide clarification of the value that is intended to be captured in the disclosure.

Effective Annual 2021

References: NAIC Editorial Revisions to the Blanks and Instructions

Updated: This adoption modifies the instructions for Note 17.B(4), adding a data-captured table to assist regulators in their assessment of situations where an entity has transferred (or sold) assets but still retains a material participation in the transferred asset. This item corresponds with the SAPWG adoption of AP&P Ref #2021-03 on May 20, 2021, and the disclosure changes required in SSAP No. 103R – Transfers and Servicing of Financial Assets and the Extinguishments of Liabilities, paragraph 28g.

Effective Annual 2021

References: 2021-05BWG Modified; SSAP No. 103R; AP&P Ref#2021-03

Updated: The instructions have been updated to reflect modifications associated with 2020-28BWG (adopted 12/16/2020) and AP&P Ref #2020-05 (adopted 7/30/2020). This item removes the data-captured table in Note 22 for 2021 Annual reporting as the Affordable Care Act (ACA) Section 9010 Assessment has been repealed effective January 1, 2021.

Effective Annual 2021

References: 2020-28BWG Modified; AP&P Ref #2020-05